[Form 4] Weyco Group Inc Insider Trading Activity

Rhea-AI Filing Summary

Thomas W. Florsheim Jr., Chairman & CEO of Weyco Group Inc. (WEYS), reported on Form 4 the acquisition of 3,100 shares of WEYS common stock on 08/25/2025 at a reported price of $0. After the transaction he beneficially owns 809,511 shares directly and holds additional indirect interests: 52,113 (wife), 268,779 (as trustee for children), 221,873 (as trustee of John Florsheim Family Trust) and 94,619 (held in 2018 irrevocable trust). He also reports several outstanding stock options exercisable through 2033 aggregating 42,000 underlying shares. The Form 4 is signed 08/27/2025.

Positive

• Substantial insider ownership: Reporting person holds 809,511 shares directly, indicating strong insider alignment with shareholders.
• Transparent disclosure of indirect family and trust holdings totaling additional significant shares, improving governance transparency.

Negative

• Unclear transaction nature: The acquisition of 3,100 shares at a reported price of $0 lacks explanation in the filing, preventing full investor understanding.
• Potential dilution: Outstanding options for 42,000 underlying shares could dilute common equity if exercised before expirations through 2033.

Insights

Corporate Governance Expert

Insider reported a small zero-price acquisition and detailed broad family and trust ownership, reinforcing long-term insider alignment.

The 3,100-share acquisition at a reported price of $0 likely reflects a non-cash issuance or transfer (the filing gives no further explanation). The reporting person remains a large insider with total direct beneficial ownership of 809,511 shares and multiple indirect holdings through family and trusts, which indicates concentrated insider ownership and alignment with shareholders. Reported option positions across grants from 2019 to 2024 vest on multi-year schedules and remain exercisable through 2028-2033, representing potential future common share dilution if exercised. The filing contains no information on the reason for the $0 price, sale transactions, or open-market purchases.

Securities Analyst

Transaction is immaterial in size but confirms continued insider exposure and multi-year option schedules.

The acquired amount (3,100 shares) is small relative to the reporting person’s total direct holdings (809,511). The $0 price is explicitly reported in the filing; absent further detail the nature of the transfer cannot be determined from this Form 4 alone. Option holdings total 42,000 underlying shares across five grants with staggered exercisability and expirations through 2033, which is relevant for potential future dilution modeling. Overall, the filing is routine disclosure of insider holdings and option grants, with limited immediate market impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLORSHEIM THOMAS W JR

(Last) (First) (Middle)

333 W. ESTABROOK BOULEVARD

(Street)

GLENDALE WI 53212

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WEYCO GROUP INC [ WEYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHAIRMAN & CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		A		3,100	A	$0	809,511	D
Common Stock								52,113	I	By Wife
Common Stock								268,779	I	As Trustee for Children
Common Stock								221,873	I	As Trustee of John Florsheim Family Trust
Common Stock								94,619	I	Held in 2018 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$37.22							08/23/2019(1)	08/23/2028	Common Stock	8,000		8,000	D
Stock Option	$18							08/26/2021(2)	08/26/2030	Common Stock	10,000		10,000	D
Stock Option	$24							08/25/2022(3)	08/25/2031	Common Stock	10,000		10,000	D
Stock Option	$28.83							08/25/2023(4)	08/25/2032	Common Stock	7,000		7,000	D
Stock Option	$25.79							08/25/2024(5)	08/25/2033	Common Stock	7,000		7,000	D

Explanation of Responses:

1. 20% per year for 5 years beginning 08/23/2019

2. 20% per year for 5 years beginning 08/26/2021

3. 20% per year for 5 years beginning 08/25/2022

4. 20% per year for 5 years beginning 08/25/2023

5. 20% per year for 5 years beginning 08/25/2024

	/s/ Thomas W. Florsheim, Jr.	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Thomas W. Florsheim Jr. report on Form 4 for WEYS?

He reported the acquisition of 3,100 shares on 08/25/2025 at a reported price of $0 and disclosed his direct beneficial ownership of 809,511 shares.

How much indirect ownership does the filing disclose for WEYS insiders?

The filing discloses indirect holdings of 52,113 (wife), 268,779 (as trustee for children), 221,873 (John Florsheim Family Trust) and 94,619 (2018 irrevocable trust).

What stock option positions does the Form 4 list for Thomas W. Florsheim Jr.?

Five option grants are listed with underlying common stock totaling 42,000 shares, exercisable and expiring between 2028 and 2033 with various exercise prices ($37.22, $18, $24, $28.83, $25.79).

Does the Form 4 explain why the shares were acquired at $0?

No. The filing reports the acquisition price as $0 but provides no explanation or additional context for the zero-price transaction.

When was the Form 4 signed by the reporting person?

The form is signed by Thomas W. Florsheim, Jr. on 08/27/2025 as shown in the filing.